Mentions
Profile
Work Department
Position
Gareth Camp specialises in advising on public bids, private acquisitions and disposals, joint ventures, group restructurings and other general corporate matters.
Gareth has worked on a number of significant transactions for clients in the healthcare and consumer goods and retail sectors, many of which have had a cross-border element. During his professional career Gareth has worked in London, New York and Dubai and in 2011 was seconded to an international healthcare company headquartered in Europe.
Career
Admitted as a solicitor in England & Wales 2002
Senior Associate at Freshfields Bruckhaus Deringer until 2012
Joined Clifford Chance as a Senior Associate 2013
Partner since 2015
Education
University of Nottingham (LLB (Hons) Law with American Law) 1999
Nottingham Trent University (Legal Practice Course) 2000
Content supplied by Clifford Chance LLP
Testimonials
Collated independently by Legal 500 research team.
- ‘They are a first-class team who are responsive to our demands and requirements, available whenever needed, and always deliver commercially focused, practical advice to help us achieve our goals.'
‘In London, Steven Fox and Katherine Moir are particularly strong, with Katherine's public M&A knowledge being crucial in an on-market transaction. They have been ably supported by Liv Higgs for many years and it was no surprise that she has been promoted to the partnership.'
‘Clifford Chance’s M&A team stands out for its exceptional technical expertise, commercial acumen, and consistently high-quality execution on complex, high-value transactions. What sets the practice apart is its seamless integration across disciplines and geographies, which enables the team to provide truly end-to-end support on cross-border deals. Their ability to combine deep legal insight with a strategic understanding of our commercial objectives was instrumental to the success of our recent transaction.'
'The team demonstrates a strong commitment to collaboration - both internally and with us as the client - which fosters a sense of trust and confidence. They are highly responsive, pragmatic, and solutions-oriented, often anticipating issues before they arise and proposing practical, business-focused resolutions. The Clifford Chance team also stands out for its clarity of communication, even on highly technical matters, which makes working with them particularly efficient.' 'Compared to other firms we have worked with, Clifford Chance has consistently demonstrated a level of consistency, reliability, and client focus that places them at the top of the market for premium M&A deals.’ ‘Very pragmatic and solution-oriented team, able to effectively manage various internal and external stakeholders at the same time. The team was able to very effectively support us during the toughest moments of the process, always coming up with actionable solutions.’‘The individuals we worked with at Clifford Chance were outstanding in every respect, consistently demonstrating deep expertise, sound judgment, and an impressive level of dedication. What sets them apart from competitors is their ability to combine top-tier legal knowledge with a strong commercial instinct, all while remaining approachable, responsive, and genuinely collaborative.'
'Katherine Moir, as lead partner, was exceptional. She provided clear strategic direction throughout the transaction, balancing technical precision with commercial pragmatism. Katherine has a calm and assured presence, which was particularly valuable in navigating complex or time-sensitive moments. Her ability to distill issues and drive consensus among stakeholders was a key factor in the smooth execution of the deal.' 'A fantastic M&A team with the ability to handle the most complex international deals. They have breadth in the team across jurisdictions, which makes them highly capable in multi-jurisdictional deals.' 'Melissa Fogarty and Alanna Hunter are must-go-to M&A lawyers for complex transactions.'
Key clients
- Schibsted Harbour Energy Avolon Aviva S&P Global Cellnex Telecom Virgin Money Saipem Informa ENI Recursion Pharmaceuticals Medlog / MSC ED&F Man SIX Group Arix Bioscience Navantia THG Citi HSBC Shell

